Brief: Camurus Withdraws Variation Application For CAM2038 To Include Chronic Pain

Camurus AB

13/02/2023 14:32

Feb 13 (Reuters) - Camurus AB  CAMX.ST :
    * CAMURUS WITHDRAWS VARIATION APPLICATION FOR CAM2038 TO
INCLUDE
CHRONIC PAIN
    * TO WITHDRAW TYPE II VARIATION APPLICATION FOR CAM2038 TO
INCLUDE
TREATMENT OF CHRONIC PAIN IN PATIENTS WITH OPIOID DEPENDENCE
    * DECISION IS BASED ON CAMURUS' ASSESSMENT OF REQUEST
FROMEMA'S
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE
    * RESULTS OF PHASE 3 TRIAL DEMONSTRATED STATISTICALLY
SIGNIFICANT,
LONG-ACTING REDUCTION OF PAIN WITH CAM2038
    * CAMURUS IS EVALUATING FURTHER CLINICAL DEVELOPMENT OF
CAM2038
FOR TREATMENT OF CHRONIC PAIN,
    * WITHDRAWAL IS NOT EXPECTED TO AFFECT CAMURUS' FINANCIAL
RESULTS
IN 2023

Source text for Eikon:  ID:nWkr11HctZ 
Further company coverage:  CAMX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))